Loading…

Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment

AbstractEpidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and g...

Full description

Saved in:
Bibliographic Details
Published in:Annals of hepatology 2014-11, Vol.13 (6), p.728-745
Main Authors: Bari, Ornella de, Wang, Tony Y, Liu, Min, Paik, Chang-Nyol, Portincasa, Piero, Wang, David Q.-H., M.D., Ph.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3
cites cdi_FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3
container_end_page 745
container_issue 6
container_start_page 728
container_title Annals of hepatology
container_volume 13
creator Bari, Ornella de
Wang, Tony Y
Liu, Min
Paik, Chang-Nyol
Portincasa, Piero
Wang, David Q.-H., M.D., Ph.D
description AbstractEpidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and gallstones are up to 30 and 12%, respectively, during pregnancy and postpartum, and 1-3% of pregnant women undergo cholecystectomy due to clinical symptoms or complications within the first year postpartum. Increased estrogen levels during pregnancy induce significant metabolic changes in the hepatobiliary system, including the formation of cholesterol-supersaturated bile and sluggish gallbladder motility, two factors enhancing cholelithogenesis. The therapeutic approaches are conservative during pregnancy because of the controversial frequency of biliary disorders. In the majority of pregnant women, biliary sludge and gallstones tend to dissolve spontaneously after parturition. In some situations, however, the conditions persist and require costly therapeutic interventions. When necessary, invasive procedures such as laparoscopic cholecystectomy are relatively well tolerated, preferably during the second trimester of pregnancy or postpartum. Although laparoscopic operation is recommended for its safety, the use of drugs such as ursodeoxycholic acid (UDCA) and the novel lipid-lowering compound, ezetimibe would also be considered. In this paper, we systematically review the incidence and natural history of pregnancy-related biliary sludge and gallstone formation and carefully discuss the molecular mechanisms underlying the lithogenic effect of estrogen on gallstone formation during pregnancy. We also summarize recent progress in the necessary strategies recommended for the prevention and the treatment of gallstones in pregnant women.
doi_str_mv 10.1016/S1665-2681(19)30975-5
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_14439e92ed934acd909fc4bc5091971e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1665268119309755</els_id><doaj_id>oai_doaj_org_article_14439e92ed934acd909fc4bc5091971e</doaj_id><sourcerecordid>1615255947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3</originalsourceid><addsrcrecordid>eNo9UctuEzEUnQWIlpZPAM2ySAz19WMcs0CqIh6VKrFou7Yc-07iMLGD7RT17_FkSlb3de450jlN8x7IZyDQX99D34uO9gu4AvWRESVFJ14156f1WfM25y0hnAmgb5ozKhijVKjz5mG5iSPmgimOrZ360ZeNN9nn1od2n3AdTCjt37jD8KXdm7KJawxY75-m6xOG4mNoTXBtSWhKhZXL5vVgxozvXupF8_j928PyZ3f368ft8uaus1zK0lFDeuY4Oi64XQEoIwVIPqg6u4URC7Jwg1kxy6yzBGoZKBMKpHG95Nyxi-Z25nXRbPU--Z1Jzzoar4-LmNbapOLtiBo4ZwoVRacYN9YpogbLV1YQBUoCVq6rmWuf4p9DdUTvfLY4jiZgPGQNPQgqhOKyQsUMtSnmnHA4SQPRUyD6GIienNeg9DEQLerfhxeJw2qH7vT1P40K-DoDsJr25DFpO_rgrRl_4zPmbTykUP3UoDPVZFaZREAdJQT7BwrvndM</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1615255947</pqid></control><display><type>article</type><title>Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment</title><source>ScienceDirect®</source><creator>Bari, Ornella de ; Wang, Tony Y ; Liu, Min ; Paik, Chang-Nyol ; Portincasa, Piero ; Wang, David Q.-H., M.D., Ph.D</creator><creatorcontrib>Bari, Ornella de ; Wang, Tony Y ; Liu, Min ; Paik, Chang-Nyol ; Portincasa, Piero ; Wang, David Q.-H., M.D., Ph.D</creatorcontrib><description>AbstractEpidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and gallstones are up to 30 and 12%, respectively, during pregnancy and postpartum, and 1-3% of pregnant women undergo cholecystectomy due to clinical symptoms or complications within the first year postpartum. Increased estrogen levels during pregnancy induce significant metabolic changes in the hepatobiliary system, including the formation of cholesterol-supersaturated bile and sluggish gallbladder motility, two factors enhancing cholelithogenesis. The therapeutic approaches are conservative during pregnancy because of the controversial frequency of biliary disorders. In the majority of pregnant women, biliary sludge and gallstones tend to dissolve spontaneously after parturition. In some situations, however, the conditions persist and require costly therapeutic interventions. When necessary, invasive procedures such as laparoscopic cholecystectomy are relatively well tolerated, preferably during the second trimester of pregnancy or postpartum. Although laparoscopic operation is recommended for its safety, the use of drugs such as ursodeoxycholic acid (UDCA) and the novel lipid-lowering compound, ezetimibe would also be considered. In this paper, we systematically review the incidence and natural history of pregnancy-related biliary sludge and gallstone formation and carefully discuss the molecular mechanisms underlying the lithogenic effect of estrogen on gallstone formation during pregnancy. We also summarize recent progress in the necessary strategies recommended for the prevention and the treatment of gallstones in pregnant women.</description><identifier>ISSN: 1665-2681</identifier><identifier>DOI: 10.1016/S1665-2681(19)30975-5</identifier><identifier>PMID: 25332259</identifier><language>eng</language><publisher>Mexico: Elsevier</publisher><subject>Anticholesteremic Agents - therapeutic use ; Azetidines - therapeutic use ; Bile - metabolism ; Bile acids ; Biliary lipids ; Biliary sludge ; Cholagogues and Choleretics - therapeutic use ; Cholecystectomy, Laparoscopic ; Cholelithiasis - metabolism ; Cholelithiasis - prevention &amp; control ; Cholelithiasis - therapy ; Cholesterol - metabolism ; Estrogen ; Estrogens - metabolism ; Ezetimibe ; Female ; Gallstones ; Gastroenterology and Hepatology ; Humans ; Pregnancy ; Pregnancy Complications - metabolism ; Pregnancy Complications - prevention &amp; control ; Pregnancy Complications - therapy ; Ursodeoxycholic Acid - therapeutic use</subject><ispartof>Annals of hepatology, 2014-11, Vol.13 (6), p.728-745</ispartof><rights>Fundación Clínica Médica Sur, A.C.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3</citedby><cites>FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25332259$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bari, Ornella de</creatorcontrib><creatorcontrib>Wang, Tony Y</creatorcontrib><creatorcontrib>Liu, Min</creatorcontrib><creatorcontrib>Paik, Chang-Nyol</creatorcontrib><creatorcontrib>Portincasa, Piero</creatorcontrib><creatorcontrib>Wang, David Q.-H., M.D., Ph.D</creatorcontrib><title>Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment</title><title>Annals of hepatology</title><addtitle>Ann Hepatol</addtitle><description>AbstractEpidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and gallstones are up to 30 and 12%, respectively, during pregnancy and postpartum, and 1-3% of pregnant women undergo cholecystectomy due to clinical symptoms or complications within the first year postpartum. Increased estrogen levels during pregnancy induce significant metabolic changes in the hepatobiliary system, including the formation of cholesterol-supersaturated bile and sluggish gallbladder motility, two factors enhancing cholelithogenesis. The therapeutic approaches are conservative during pregnancy because of the controversial frequency of biliary disorders. In the majority of pregnant women, biliary sludge and gallstones tend to dissolve spontaneously after parturition. In some situations, however, the conditions persist and require costly therapeutic interventions. When necessary, invasive procedures such as laparoscopic cholecystectomy are relatively well tolerated, preferably during the second trimester of pregnancy or postpartum. Although laparoscopic operation is recommended for its safety, the use of drugs such as ursodeoxycholic acid (UDCA) and the novel lipid-lowering compound, ezetimibe would also be considered. In this paper, we systematically review the incidence and natural history of pregnancy-related biliary sludge and gallstone formation and carefully discuss the molecular mechanisms underlying the lithogenic effect of estrogen on gallstone formation during pregnancy. We also summarize recent progress in the necessary strategies recommended for the prevention and the treatment of gallstones in pregnant women.</description><subject>Anticholesteremic Agents - therapeutic use</subject><subject>Azetidines - therapeutic use</subject><subject>Bile - metabolism</subject><subject>Bile acids</subject><subject>Biliary lipids</subject><subject>Biliary sludge</subject><subject>Cholagogues and Choleretics - therapeutic use</subject><subject>Cholecystectomy, Laparoscopic</subject><subject>Cholelithiasis - metabolism</subject><subject>Cholelithiasis - prevention &amp; control</subject><subject>Cholelithiasis - therapy</subject><subject>Cholesterol - metabolism</subject><subject>Estrogen</subject><subject>Estrogens - metabolism</subject><subject>Ezetimibe</subject><subject>Female</subject><subject>Gallstones</subject><subject>Gastroenterology and Hepatology</subject><subject>Humans</subject><subject>Pregnancy</subject><subject>Pregnancy Complications - metabolism</subject><subject>Pregnancy Complications - prevention &amp; control</subject><subject>Pregnancy Complications - therapy</subject><subject>Ursodeoxycholic Acid - therapeutic use</subject><issn>1665-2681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNo9UctuEzEUnQWIlpZPAM2ySAz19WMcs0CqIh6VKrFou7Yc-07iMLGD7RT17_FkSlb3de450jlN8x7IZyDQX99D34uO9gu4AvWRESVFJ14156f1WfM25y0hnAmgb5ozKhijVKjz5mG5iSPmgimOrZ360ZeNN9nn1od2n3AdTCjt37jD8KXdm7KJawxY75-m6xOG4mNoTXBtSWhKhZXL5vVgxozvXupF8_j928PyZ3f368ft8uaus1zK0lFDeuY4Oi64XQEoIwVIPqg6u4URC7Jwg1kxy6yzBGoZKBMKpHG95Nyxi-Z25nXRbPU--Z1Jzzoar4-LmNbapOLtiBo4ZwoVRacYN9YpogbLV1YQBUoCVq6rmWuf4p9DdUTvfLY4jiZgPGQNPQgqhOKyQsUMtSnmnHA4SQPRUyD6GIienNeg9DEQLerfhxeJw2qH7vT1P40K-DoDsJr25DFpO_rgrRl_4zPmbTykUP3UoDPVZFaZREAdJQT7BwrvndM</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Bari, Ornella de</creator><creator>Wang, Tony Y</creator><creator>Liu, Min</creator><creator>Paik, Chang-Nyol</creator><creator>Portincasa, Piero</creator><creator>Wang, David Q.-H., M.D., Ph.D</creator><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20141101</creationdate><title>Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment</title><author>Bari, Ornella de ; Wang, Tony Y ; Liu, Min ; Paik, Chang-Nyol ; Portincasa, Piero ; Wang, David Q.-H., M.D., Ph.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Anticholesteremic Agents - therapeutic use</topic><topic>Azetidines - therapeutic use</topic><topic>Bile - metabolism</topic><topic>Bile acids</topic><topic>Biliary lipids</topic><topic>Biliary sludge</topic><topic>Cholagogues and Choleretics - therapeutic use</topic><topic>Cholecystectomy, Laparoscopic</topic><topic>Cholelithiasis - metabolism</topic><topic>Cholelithiasis - prevention &amp; control</topic><topic>Cholelithiasis - therapy</topic><topic>Cholesterol - metabolism</topic><topic>Estrogen</topic><topic>Estrogens - metabolism</topic><topic>Ezetimibe</topic><topic>Female</topic><topic>Gallstones</topic><topic>Gastroenterology and Hepatology</topic><topic>Humans</topic><topic>Pregnancy</topic><topic>Pregnancy Complications - metabolism</topic><topic>Pregnancy Complications - prevention &amp; control</topic><topic>Pregnancy Complications - therapy</topic><topic>Ursodeoxycholic Acid - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bari, Ornella de</creatorcontrib><creatorcontrib>Wang, Tony Y</creatorcontrib><creatorcontrib>Liu, Min</creatorcontrib><creatorcontrib>Paik, Chang-Nyol</creatorcontrib><creatorcontrib>Portincasa, Piero</creatorcontrib><creatorcontrib>Wang, David Q.-H., M.D., Ph.D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Annals of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bari, Ornella de</au><au>Wang, Tony Y</au><au>Liu, Min</au><au>Paik, Chang-Nyol</au><au>Portincasa, Piero</au><au>Wang, David Q.-H., M.D., Ph.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment</atitle><jtitle>Annals of hepatology</jtitle><addtitle>Ann Hepatol</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>13</volume><issue>6</issue><spage>728</spage><epage>745</epage><pages>728-745</pages><issn>1665-2681</issn><abstract>AbstractEpidemiological and clinical studies have found that gallstone prevalence is twice as high in women as in men at all ages in every population studied. Hormonal changes occurring during pregnancy put women at higher risk. The incidence rates of biliary sludge (a precursor to gallstones) and gallstones are up to 30 and 12%, respectively, during pregnancy and postpartum, and 1-3% of pregnant women undergo cholecystectomy due to clinical symptoms or complications within the first year postpartum. Increased estrogen levels during pregnancy induce significant metabolic changes in the hepatobiliary system, including the formation of cholesterol-supersaturated bile and sluggish gallbladder motility, two factors enhancing cholelithogenesis. The therapeutic approaches are conservative during pregnancy because of the controversial frequency of biliary disorders. In the majority of pregnant women, biliary sludge and gallstones tend to dissolve spontaneously after parturition. In some situations, however, the conditions persist and require costly therapeutic interventions. When necessary, invasive procedures such as laparoscopic cholecystectomy are relatively well tolerated, preferably during the second trimester of pregnancy or postpartum. Although laparoscopic operation is recommended for its safety, the use of drugs such as ursodeoxycholic acid (UDCA) and the novel lipid-lowering compound, ezetimibe would also be considered. In this paper, we systematically review the incidence and natural history of pregnancy-related biliary sludge and gallstone formation and carefully discuss the molecular mechanisms underlying the lithogenic effect of estrogen on gallstone formation during pregnancy. We also summarize recent progress in the necessary strategies recommended for the prevention and the treatment of gallstones in pregnant women.</abstract><cop>Mexico</cop><pub>Elsevier</pub><pmid>25332259</pmid><doi>10.1016/S1665-2681(19)30975-5</doi><tpages>18</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1665-2681
ispartof Annals of hepatology, 2014-11, Vol.13 (6), p.728-745
issn 1665-2681
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_14439e92ed934acd909fc4bc5091971e
source ScienceDirect®
subjects Anticholesteremic Agents - therapeutic use
Azetidines - therapeutic use
Bile - metabolism
Bile acids
Biliary lipids
Biliary sludge
Cholagogues and Choleretics - therapeutic use
Cholecystectomy, Laparoscopic
Cholelithiasis - metabolism
Cholelithiasis - prevention & control
Cholelithiasis - therapy
Cholesterol - metabolism
Estrogen
Estrogens - metabolism
Ezetimibe
Female
Gallstones
Gastroenterology and Hepatology
Humans
Pregnancy
Pregnancy Complications - metabolism
Pregnancy Complications - prevention & control
Pregnancy Complications - therapy
Ursodeoxycholic Acid - therapeutic use
title Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T04%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cholesterol%20cholelithiasis%20in%20pregnant%20women:%20pathogenesis,%20prevention%20and%20treatment&rft.jtitle=Annals%20of%20hepatology&rft.au=Bari,%20Ornella%20de&rft.date=2014-11-01&rft.volume=13&rft.issue=6&rft.spage=728&rft.epage=745&rft.pages=728-745&rft.issn=1665-2681&rft_id=info:doi/10.1016/S1665-2681(19)30975-5&rft_dat=%3Cproquest_doaj_%3E1615255947%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-2a063d4ed454cb119a75174f9454d8a5808dfab3c3cdc01c3cf235917ad6744d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1615255947&rft_id=info:pmid/25332259&rfr_iscdi=true